Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1
Recruiting1
Terminated1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT05307237Not ApplicableCompleted
Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)
Type 2 Diabetes
PrincipalinvestigatorStart date: 2022-04-19
NCT04933851Phase 2Recruiting
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes
Type 1 Diabetes
PrincipalinvestigatorStart date: 2021-10-25
NCT04269655Not ApplicableTerminated
Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)
Diabetes Mellitus, Type 2
StudydirectorStart date: 2020-02-25

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Scripps Whittier Diabetes Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Athena Philis-Tsimikas, MD

Scripps Whittier Diabetes Institute

Moderately Similar
12 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

DexCom, Inc.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+1 more
Collaborated on 3 trials
Similarity Score32%

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Moderately Similar
16 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Moderately Similar
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score30%

Roman Hovorka, PhD

University of Cambridge

Moderately Similar
13 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score30%

Lisa Porter, MD

Amylin Pharmaceuticals, LLC.

Moderately Similar
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score30%

Samuel Klein, MD

Washington University School of Medicine

Moderately Similar
30 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score30%

Bruce Bode, MD

Atlanta Diabetes Associates

Moderately Similar
8 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Timothy Bailey, MD

AMCR Institute

Moderately Similar
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score30%

Adrian Vella, MD

Mayo Clinic

Moderately Similar
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score30%

Mustafa H Temel, M.D.

Uskudar State Hospital

Moderately Similar
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05307237Not ApplicablePrincipalInvestigator

Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)

Type 2 Diabetes
Completed
NCT04933851Phase 2PrincipalInvestigator

ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

Type 1 Diabetes
Recruiting
NCT04269655Not ApplicableStudyDirector

Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)

Diabetes Mellitus, Type 2
Terminated

All 3 trials loaded